Lymphocyte β-adrenergic receptor binding in panic disorder

Psychopharmacology

Volumn 94, Issue 1, 1988, Pages 24-28

  Brown, S L ^a   Charney, D S ^b,c   Woods, S W ^b,c   Heninger, G R ^b,c   Tallman, J ^b,c  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b Yale University School of Medicine   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adrenergic receptors; Anxiety; Lymphocytes; Noradrenergic dysfunction; Panic disorder

Indexed keywords

BETA ADRENERGIC RECEPTOR; CYANOPINDOLOL I 125;

AGORAPHOBIA; CLINICAL ARTICLE; DEPRESSION; DRUG RECEPTOR BINDING; HUMAN; HUMAN EXPERIMENT; LYMPHOCYTE; METHODOLOGY; NORMAL HUMAN; PANIC; PATIENT; PSYCHOLOGICAL ASPECT; VOLUNTEER;

ADRENERGIC BETA-AGONISTS; ADRENERGIC BETA-ANTAGONISTS; ADULT; AGORAPHOBIA; DEPRESSIVE DISORDER; FEAR; FEMALE; GUANOSINE TRIPHOSPHATE; HUMAN; IODINE RADIOISOTOPES; IODOCYANOPINDOLOL; KINETICS; LYMPHOCYTES; MALE; MIDDLE AGE; PANIC; PHOBIC DISORDERS; PINDOLOL; PSYCHIATRIC STATUS RATING SCALES; RECEPTORS, ADRENERGIC, BETA; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0023815967     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/BF00735875     Document Type: Article

References (38)

1. Separation of leucocytes from blood and bone marrow
2. The psychophysiology of anxiety: With a review of literature concerning adrenaline
3. The diagnostic validity of anxiety disorders and their relationship to depressive illness
4. The β-adrenergic receptor in human lymphocytes: Subclassification by the use of a new radioligand, (+)-125Iodocyanopindolol
5. Human β-adrenoceptors: Relation of myocardial and lymphocyte β-adrenoceptor density
6. β-adrenergic receptors
7. Platelet α2-adrenergic receptor binding and plasma catecholamines: Before and during imipramine treatment in patients with panic anxiety
8. Noradrenergic function and the mechanism of action of antianxiety treatment: II. The effect of long term imipramine treatment
9. Abrupt discontinuation of tricyclic antidepressant drugs: Evidence for noradrenergic hyperactivity
10. Naltrexone precipitated opiate withdrawal in methadone addicted human subjects: Evidence for noradrenergic hyperactivity
11. Noradrenergic function in panic anxiety: Effects of yohimbine in healthy subjects and patients with agoraphobia and panic disorder
12. Abnormal regulation of noradrenergic function in panic disorders
13. Magnesium and GTP affect the interactions of antagonists with β-adrenergic receptors on membranes from rat lung and S49 lymphoma cells
14. Changes in lymphocyte beta-adrenergic receptors in depression and mania
15. Biphasic regulation of lymphocyte β-adrenoceptor density by physiological catecholamines in man
16. Regulation of human leukocyte beta receptors by endogenous catecholamines. Relationship of leukocyte beta receptor density to the cardiac sensitivity to isoproterenol
17. A rating scale for depression
18. Diagnosis and ratings of anxiety
19. Autonomic and psychiatric effects of yohimbine hydrochloride
20. The peripheral and central role of the catecholamines in the mechanisms of anxiety
21. Regulation of β-adrenergic response in human lymphocytes: Agonist-induced subsensitivity
22. Protein measurement with the Folin phenol reagent
23. Reduced sensitivity of lymphocyte beta-adrenergic receptors in patients with endogenous depression and psychomotor agitation
24. B1-and B2-adrenergic β1 and β2 receptors in rat cerebral cortex are independently regulated
25. Adrenergic function in patients with panic anxiety
26. Urinary catecholamines and mitral valve prolapse in panic-anxiety patients
27. Endocrine and cardiovascular responses during phobic anxiety
28. Beta-adrenergic receptor function in affective illness
29. α-adrenergic receptors in neural tissues: methods and applications of radioligand binding assays
30. CSF norepinephrine in affective illness
31. Neurochemical basis for anxiety and anxiety disorders: Evidence from drugs which decrease human fear or anxiety
32. Molecular mechanisms of receptor desensitization using the β-adrenergic receptor-coupled adenylate cyclase system as a model
33. State anxiety and urinary MHPG
34. Identification of β-adrenergic receptors in human lymphocytes by (-)[3H] alprenolol binding
35. β-adrenoceptor binding defects in cell lines from families with manic-depressive disorder
36. Resting catecholamine concentrations in patients with depression and anxiety
37. Treatment of phobias: Comparison of imipramine hydrochloride and placebo